Omeros (OMER) Gross Margin (2014 - 2026)
Omeros recorded quarterly Gross Margin of 94.07% in Q1 2026, down 4.88% quarter-over-quarter from 98.89% in Q3 2021.
Omeros' Gross Margin history runs 9 years deep, the most recent figure standing at 94.07% for Q1 2026.
- In Q1 2026, Gross Margin changed N/A year-over-year to 94.07%; the TTM figure through Mar 2026 stood at 98.16% (down 66.0% YoY), while the FY2020 annual figure was 98.78%, down 45.0% from the prior year.
- Gross Margin came in at 94.07% for Q1 2026 at Omeros, down from 98.89% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.07% in Q1 2026 to a low of 94.07% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 94.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.07% |
| Sep 30, 2021 | 98.89% |
| Jun 30, 2021 | 98.81% |
| Mar 31, 2021 | 98.75% |
| Dec 31, 2020 | 99.18% |
| Sep 30, 2020 | 98.46% |
| Jun 30, 2020 | 98.91% |
| Mar 31, 2020 | 98.87% |
| Dec 31, 2019 | 98.80% |
| Sep 30, 2019 | 99.07% |
| Jun 30, 2019 | 99.79% |
| Mar 31, 2019 | 99.40% |
| Dec 31, 2018 | 99.29% |
| Sep 30, 2018 | 99.22% |
| Jun 30, 2018 | 92.99% |
| Mar 31, 2018 | 87.22% |
| Dec 31, 2017 | 96.62% |
| Sep 30, 2017 | 99.15% |
| Jun 30, 2017 | 99.08% |
| Mar 31, 2017 | 97.79% |
| Dec 31, 2016 | 97.06% |
| Sep 30, 2016 | 96.65% |
| Jun 30, 2016 | 96.73% |
| Mar 31, 2016 | 95.59% |
| Dec 31, 2015 | 93.75% |
| Sep 30, 2015 | 92.39% |
| Jun 30, 2015 | 88.55% |
| Mar 31, 2015 | 97.16% |
| Dec 31, 2014 | 100.00% |
| Sep 30, 2014 | 100.00% |
| Jun 30, 2014 | 100.00% |
| Mar 31, 2014 | 100.00% |